- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
Patent holdings for IPC class C07K 16/40
Total number of patents in this class: 5488
10-year publication summary
|
444
|
427
|
435
|
431
|
439
|
385
|
415
|
397
|
427
|
199
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4727 |
140 |
| Genentech, Inc. | 4110 |
120 |
| Hoffmann-La Roche Inc. | 3796 |
115 |
| Amgen Inc. | 4429 |
92 |
| Omeros Corporation | 306 |
89 |
| F. Hoffmann-La Roche AG | 7819 |
88 |
| The Regents of the University of California | 20778 |
78 |
| Takeda Pharmaceutical Company Limited | 2710 |
75 |
| aTyr Pharma, Inc. | 167 |
74 |
| Pangu BioPharma Limited | 106 |
69 |
| University of Leicester | 217 |
48 |
| Novartis AG | 10251 |
43 |
| Janssen Biotech, Inc. | 1769 |
43 |
| Immatics Biotechnologies GmbH | 1126 |
39 |
| Dana-Farber Cancer Institute, Inc. | 2665 |
36 |
| The Johns Hopkins University | 5887 |
35 |
| Mayo Foundation for Medical Education and Research | 3386 |
34 |
| Kymab Limited | 275 |
34 |
| The Trustees of the University of Pennsylvania | 4416 |
33 |
| Chugai Seiyaku Kabushiki Kaisha | 1423 |
31 |
| Other owners | 4172 |